Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • When Immigrant Parents Are Arrested
  • Sandwiched Caregivers
  • Medical Debt
  • Rising Health Costs
  • Ivermectin Sales

WHAT'S NEW

  • When Immigrant Parents Are Arrested
  • Sandwiched Caregivers
  • Medical Debt
  • Rising Health Costs
  • Ivermectin Sales

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jun 25 2026 9:09 AM

Full Issue

Amid Nationwide Shortage Of Chemo Drugs, Some Cancer Patients Are Being Prioritized For Treatment

The New York Times reports the shortages were brought on by manufacturing difficulties, shipping delays, and decisions by some companies to stop producing the medications altogether, according to the FDA.

The New York Times: Shortage Of Chemotherapy Drugs Brings Rationing Fears For Cancer Patients

Doctors treating cancer patients nationwide are facing a shortage of essential generic chemotherapy drugs, a situation that many fear could lead to widespread rationing. The shortages stem from manufacturing problems, shipping delays and decisions by some companies to stop producing the medications, according to the Food and Drug Administration. (Jewett, 6/24)

In other pharma and tech news —

Stat: Eli Lilly Dives Into Hair Loss Treatments With Investment In AI Startup Absci 

The pharmaceutical giants behind the monumentally successful weight loss drugs Wegovy and Mounjaro have been teasing an expansion into other aesthetic fields like hair loss or skin care. Now, one of them is making a move, investing in a small startup developing a medication to spur hair growth, and potentially also treat endometriosis. (DeAngelis, 6/24)

MedPage Today: How A Drug With More Negative Than Positive Studies Won FDA Approval

The FDA should require negative studies of a new drug to be included in the product's labeling -- not just those studies with a beneficial finding -- to prevent physicians and consumers from being misled about the drug's safety and efficacy. That's the conclusion of researchers who examined the nearly decades-long journey of rejections that led up to the FDA's final approval of gepirone extended release (Exxua) for major depressive disorder in 2023, despite scant evidence of effectiveness. The findings were published in JAMA Psychiatry. (Clark, 6/24)

KFF Health News: Opioid Settlement Money Pays For Services To Battle Addiction In Rural Kentucky

Drugs and the consequences of addiction are woven into the fabric of Jamie Madden’s life. Her earliest memory is of standing on the passenger seat of her dad’s car as a toddler, wearing a peach-colored blouse, while he drove from their Kentucky home to Florida to pick up drugs. On a stop for a burger, she met Ronald McDonald. “I grew up with the impression that that’s how you paid your bills,” Madden said. “That’s how your kids got things.” (Sisk, 6/25)

KFF Health News: Listen To The Latest ‘KFF Health News Minute’ 

Zach Dyer reads the week’s news: The U.S. is getting its first new sunscreen ingredient in decades. Plus, at-home cancer tests have their limits. (Zenda, 6/25)

Also —

Chicago Tribune: Wheaton Woman, 87, Is Oldest Known Kidney Recipient In Illinois

When Sheila Perry learned that she was a record-setter at 87 years old, she was surrounded by family, and all the group could do was laugh. Indeed, they had much to smile about. The Wheaton local is the oldest known female in Illinois — and among the oldest in the United States — to have a successful kidney transplant. (Kiehl, 6/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, June 25
  • Wednesday, June 24
  • Tuesday, June 23
  • Monday, June 22
  • Thursday, June 18
  • Wednesday, June 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF